LYEL
Price
$1.73
Change
+$0.06 (+3.59%)
Updated
Nov 30, 6:59 PM EST
117 days until earnings call
PDSB
Price
$5.26
Change
+$0.12 (+2.33%)
Updated
Nov 30, 6:59 PM EST
119 days until earnings call
Ad is loading...

Compare predictions LYEL vs PDSB

Header iconLYEL vs PDSB Comparison
Open Charts LYEL vs PDSBBanner chart's image
Lyell Immunopharma
Price$1.73
Change+$0.06 (+3.59%)
Volume$509.31K
CapitalizationN/A
PDS Biotechnology
Price$5.26
Change+$0.12 (+2.33%)
Volume$468K
CapitalizationN/A
View a ticker or compare two or three
LYEL vs PDSB Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
LYEL vs. PDSB commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and PDSB is a Hold.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (LYEL: $1.73 vs. PDSB: $5.26)
Brand notoriety: LYEL and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 58% vs. PDSB: 89%
Market capitalization -- LYEL: $395.43M vs. PDSB: $183.54M
LYEL [@Biotechnology] is valued at $395.43M. PDSB’s [@Biotechnology] market capitalization is $183.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 1 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 1 green, 4 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, LYEL is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 5 bearish.
  • PDSB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both LYEL and PDSB are a good buy in the short-term.

Price Growth

LYEL (@Biotechnology) experienced а 0.00% price change this week, while PDSB (@Biotechnology) price change was -14.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +26.89%, and the average quarterly price growth was +20.28%.

Reported Earning Dates

LYEL is expected to report earnings on Mar 26, 2024.

PDSB is expected to report earnings on Mar 28, 2024.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for LYEL with price predictions.
OPEN
A.I.dvisor published
a Summary for PDSB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LYEL($395M) has a higher market cap than PDSB($184M). LYEL YTD gains are higher at: -50.144 vs. PDSB (-60.152). PDSB has higher annual earnings (EBITDA): -48.62M vs. LYEL (-182.05M). LYEL has more cash in the bank: 575M vs. PDSB (54.3M). PDSB has less debt than LYEL: PDSB (23.6M) vs LYEL (58.6M). LYEL has higher revenues than PDSB: LYEL (48.5M) vs PDSB (0).
LYELPDSBLYEL / PDSB
Capitalization395M184M215%
EBITDA-182.05M-48.62M374%
Gain YTD-50.144-60.15283%
P/E Ratio3.02N/A-
Revenue48.5M0-
Total Cash575M54.3M1,059%
Total Debt58.6M23.6M248%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELPDSB
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPGLX9.90N/A
N/A
MassMutual Disciplined Gr Adm
MDCPX23.72N/A
N/A
BlackRock Sustainable Balanced Inv A
BSMAX13.85N/A
N/A
iShares Russell Small/Mid-Cap Idx Inv A
FEMMX34.48N/A
N/A
Fidelity Advisor® Emerging Markets C
ADMZX7.50N/A
N/A
Allspring U.S. Long/Short Equity Inst

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+3.59%
DNLI - LYEL
53%
Loosely correlated
+0.71%
NTLA - LYEL
49%
Loosely correlated
-4.20%
ADPT - LYEL
48%
Loosely correlated
-5.19%
MDGL - LYEL
46%
Loosely correlated
+3.01%
AGEN - LYEL
44%
Loosely correlated
+10.92%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+2.33%
AXON - PDSB
43%
Loosely correlated
+1.78%
MDGL - PDSB
38%
Loosely correlated
+3.01%
VCYT - PDSB
37%
Loosely correlated
-0.51%
VERA - PDSB
35%
Loosely correlated
+1.50%
ARRY - PDSB
35%
Loosely correlated
+3.76%
More